Ninety One UK Ltd Increases Stake in Boston Scientific Corporation

The investment firm added to its position in the medical device company during the fourth quarter.

Apr. 18, 2026 at 11:42am

Got story updates? Submit your updates here. ›

An extreme close-up of highly detailed, metallic medical device components and machinery, conveying the complex, industrial nature of Boston Scientific's business.Ninety One UK Ltd's increased investment in Boston Scientific signals continued confidence in the medical device company's growth potential.Marlborough Today

Ninety One UK Ltd, a major investment firm, increased its stake in Boston Scientific Corporation by 1.5% during the fourth quarter of 2025, according to a recent SEC filing. The firm now owns 5,444,549 shares of the medical equipment provider's stock, making it a top 26th position in its portfolio.

Why it matters

This investment move by Ninety One UK Ltd signals continued confidence in Boston Scientific's long-term growth potential within the medical device industry. As a large institutional investor, Ninety One's increased stake could influence other investors and impact the stock price.

The details

Ninety One UK Ltd acquired an additional 81,023 shares of Boston Scientific during the fourth quarter, bringing its total ownership to 0.37% of the company. Boston Scientific is a global medical device manufacturer focused on less-invasive procedures across cardiovascular, digestive, urologic, and other medical fields.

  • Ninety One UK Ltd increased its stake in the fourth quarter of 2025.
  • The filing with the SEC disclosing this position change was made on April 18, 2026.

The players

Ninety One UK Ltd

A major investment management firm that owns a significant stake in Boston Scientific Corporation.

Boston Scientific Corporation

A global medical device company that develops and markets products for less-invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

As a major institutional investor, Ninety One UK Ltd's increased position in Boston Scientific could influence other investors and impact the stock price, reflecting ongoing confidence in the medical device company's future performance.